Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Uveal Melanoma × aldesleukin × Clear all

Phase

Status

Unknown 1 Terminated 1 Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 7 Stomach Neoplasms 5 Pancreatic Neoplasms 4 Ovarian Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Breast Neoplasms 4 Skin Neoplasms 3 Neoplasm Metastasis 3 Leukemia, Myeloid, Acute 3 Carcinoma, Renal Cell 3 Uterine Cervical Neoplasms 2 Urogenital Neoplasms 2 Rectal Neoplasms 2 Neuroblastoma 2 Myelodysplastic Syndromes 2 Multiple Myeloma 2 Lung Neoplasms 2 Leukemia, Myeloid 2 Leukemia 2 Hematologic Neoplasms 2 Gastrointestinal Neoplasms 2 Colonic Neoplasms 2 Carcinoma, Merkel Cell 2 Vulvar Neoplasms 1 Vaginal Neoplasms 1 Uveal Melanoma 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1

Interventions

tebentafusp 3 Nivolumab 3 pembrolizumab 2 cemiplimab 2 Magnetic Resonance Spectroscopy 2 Ipilimumab 2 Cyclophosphamide 2 sargramostim 1 quisinostat 1 olaparib 1 fludarabine phosphate 1 fludarabine 1 binimetinib 1 aldesleukin 1 aflibercept 1 Tape Recording 1 Specimen Handling 1 Radiosurgery 1 Protein Kinase C 1 Melatonin 1 Interleukin-2 1 Interleukin-13 1 Immunotherapy 1 Hematologic Tests 1 Granulocyte-Macrophage Colony-Stimulating Factor 1 Fluorodeoxyglucose F18 1 Exercise 1 Crizotinib 1 Carmustine 1 Biopsy 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07063875 2025-07-14

SILVER

St Vincent's Hospital, Sydney

Phase 1/2 Recruiting

Uveal Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡